Imaging of Traumatic Brain Injury Metabolism Using Hyperpolarized Carbon-13 Pyruvate
Status:
Enrolling by invitation
Trial end date:
2025-06-30
Target enrollment:
Participant gender:
Summary
This project is to evaluate sensitivity and specificity of hyperpolarized 13C-pyruvate as
imaging agents of altered cerebral glycolysis and mitochondrial dysfunction and assess
pyruvate utilization in mitochondria in Traumatic Brain Injury (TBI) patients.